Targeting cancer therapy.
Begent
R H
RH
CRC Targeting and Imaging Group, Department of Oncology, Royal Free Medical School, London, UK.
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011355:Prodrugs / Q000627:therapeutic use
D000906:Antibodies; D019496:Cancer Vaccines; D018796:Immunoconjugates; D011355:Prodrugs